Tests:CA 125: Difference between revisions

Tests:CA 125
No edit summary
No edit summary
Line 4: Line 4:


{| class="wikitable"
{| class="wikitable"
! colspan="2" |''Overview''
! colspan="2" |
== Overview ==
|-
|-
|Department
|Department
Line 15: Line 16:
|C125
|C125
C-125
C-125
C12-5
C12-5
|-
|Test Availability
|Tuesday and Thursday
Contact lab if testing is required urgently
|-
|-
|Turnaround Time
|Turnaround Time
Line 24: Line 30:
|-
|-
! colspan="2" |
! colspan="2" |
===''Specimen Requirements''===
== Specimen Requirements ==
|-
|-
|Specimen Type
|Specimen Type
|Serum
|Serum
Plasma
Plasma
|-
|Specimen Transportation
|
|-
|-
|Preferred
|Preferred
|7mL <span style="background:#e30022"> Red-Top </span>,
|7mL <span style="background:#e30022"> Red-Top </span>
|-
|-
|Acceptable
|Acceptable
|SST <span style="background: #fbec5d"> Yellow-Top</span>
|SST <span style="background: #fbec5d"> Yellow-Top</span>
|-
|-
|Specimen Transportation
|Unacceptable
|
|
|-
|-
|Pediatric Requirements
|Paediatric Requirements
|0.5 <span style="background:#e30022"> Red </span> microtainer  
|0.5 <span style="background:#e30022"> Red </span> microtainer  
|-
|-
! colspan="2" |
! colspan="2" |
===''Aliquot Requirements''===
== Aliquot Requirements ==
|-
|-
|Sample Type
|Sample Type
|>500 uL Serum
|Serum
|-
|Preferred Volume
|>500 uL
|-
|-
|Minimum Volume
|Minimum Volume
|200 uL Serum 
|200 uL
|-
|-
|Aliquot Transportation
|Aliquot Transportation
|Samples should be separated from red cells within 24hrs of collection. 
|Samples should be separated from red cells within 24hrs of collection. 
|-
|-
! colspan="2" |''Clinical Information''
! colspan="2" |
== Clinical Information ==
|-
|-
|Reference Intervals
|Reference Intervals
Line 70: Line 83:
|
|
|-
|-
| colspan="2" |Comments
! colspan="2" |
== Comments ==
|-
|-
| colspan="2" |Tested Tuesdays and Fridays.  Please contact the laboratory if testing required urgently.
| colspan="2" |Used for monitoring Ovarian Carcinoma.
 
Used for monitoring Ovarian Carcinoma.  


For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.
|}
|}